Niclosamide and Ovarian Cancer: Patient-Friendly Research Guide

By Insight Swarm Research Team, Medical Advisor: Nikhil Joshi, MD, FRCPC

Niclosamide and Ovarian Cancer: A Patient-Friendly Research Overview

If you or a loved one has Ovarian Cancer and you've heard about Niclosamide, this guide explains what the research actually shows in plain language. We believe patients deserve honest, clear information — not hype, not dismissal. This is a research summary only. Always work with your gynecologic oncologist.

What is Niclosamide?

Niclosamide is classified as a Antiparasitic / Salicylamide. In simple terms, it works by: Inhibits Wnt/β-catenin, Notch, mTOR, STAT3, and NF-κB signaling; uncouples mitochondrial OXPHOS...

Its current regulatory status: FDA-approved for intestinal tapeworm; not approved for cancer

Why Are Ovarian Cancer Patients Asking About Niclosamide?

Researchers and patients with Ovarian Cancer have explored Niclosamide because of its specific mechanisms that may be relevant to Ovarian Cancer biology. This has generated both scientific publications and patient community interest.

What the Research Actually Shows

Evidence level: Preclinical + Phase I trials; bioavailability challenges being addressed

This means: There is scientific research specifically examining this combination, providing more than just theoretical interest.

Safety in Plain Language

What you should know about Niclosamide safety: Excellent systemic safety historically; new formulations alter profile; nausea most common

Important: even compounds with favorable safety profiles can have risks in Ovarian Cancer patients due to interactions with treatment or disease-related organ changes.

Questions to Bring to Your Gynecologic Oncologist

  • Has Niclosamide been studied for Ovarian Cancer? What does the evidence show?
  • Could Niclosamide interact with my current Ovarian Cancer treatment?
  • Are there clinical trials involving Niclosamide that I might be eligible for?
  • What monitoring would be needed if I were to try Niclosamide?
  • What are the alternatives that have stronger evidence?

How to Research Further

For continued research: PubMed (pubmed.ncbi.nlm.nih.gov) for peer-reviewed studies, ClinicalTrials.gov for active trials, and insightswarm.ai for a personalized AI-generated research report tailored to your specific case.

Medical Disclaimer: This page summarizes published research and is not medical advice. Never start, stop, or change any treatment based on information found online. Always consult qualified healthcare professionals before making treatment decisions.

Get a personalized AI-generated research report at insightswarm.ai.

Frequently Asked Questions

Can Niclosamide cure Ovarian Cancer?

No compound has been proven to cure Ovarian Cancer, and Niclosamide is no exception. The current evidence for Niclosamide in Ovarian Cancer is: Preclinical + Phase I trials; bioavailability challenges being addressed. Be cautious of any source claiming a cure.

Is Niclosamide worth trying for Ovarian Cancer?

Whether Niclosamide is worth considering for your specific Ovarian Cancer case is a decision that requires your gynecologic oncologist's assessment. The published research (Preclinical + Phase I trials; bioavailability challenges being addressed) can inform that conversation, but individual factors matter enormously.

Where can I learn more about Niclosamide for Ovarian Cancer?

Reliable sources: PubMed for peer-reviewed research, ClinicalTrials.gov for trials, your gynecologic oncologist, and insightswarm.ai for a personalized research report. Be critical of forums and social media, which often amplify anecdotal reports.